Why the study?
Neurogenic stress cardiomyopathy is a significant complication of aneurysmal subarachnoid hemorrhage, but whether hsTnT and NTproBNP help predict its occurrence remained to be assessed.
Do serial measurements of hsTnT and NTproBNP predict neurogenic stress cardiomyopathy in patients with aneurysmal subarachnoid hemorrhage?
Do serial measurements of hsTnT and NTproBNP predict neurogenic stress cardiomyopathy in patients with aneurysmal subarachnoid hemorrhage?
Peak levels of hsTnT and NTproBNP can help predict the development of neurogenic stress cardiomyopathy in the early phase of aneurysmal subarachnoid hemorrhage.
Serial hsTnT/NTproBNP monitoring may aid early NSC identification post-aSAH; leaves open prospective validation before routine use.
BACKGROUND: Neurogenic stress cardiomyopathy (NSC), also known as stress-induced cardiomyopathy (SIC), is a significant complication of aneurysmal subarachnoid hemorrhage and an important contributor to morbidity mortality. OBJECTIVE: This prospective observational study assessed whether the high sensitive troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NTproBNP) helps in the prediction of NSC after SAH. METHODS: The consecutive patients with aSAH without any cardiac history were included prospectively over 12 months. Neurological assessment for the grade of SAH (Hunt & Hess and WFNS grade), electrocardiogram, and echocardiography done at admission. The serial measurements of serum hsTnT and NTproBNP for consecutive 7 days done. The NSC is defined as transient hypokinesia of the ventricular wall on echocardiography. RESULTS: The study included 69 patients, and 7 (10.1%) were diagnosed with NSC. The NSC had a positive correlation with Hunt and Hess grade (P = 0.010), and the serum levels of hsTnT and NTproBNP were higher in patients with NSC in comparison to without NSC over all 7 days. The peak levels of hsTnT and NTproBNP were significantly higher in patients with cardiomyopathy (P = 0.000 and 0.032, respectively). The best cut-off level of peak hsTnT was 0.032 pg/dl to predict cardiomyopathy with sensitivity and specificity of 100% and 80%, respectively, and NTproBNP was 430.6 ng/dL with sensitivity and specificity of 86% and 73%, respectively. CONCLUSION: The peak levels of hsTnT and NTproBNP with abnormal ECG and echocardiography at admission help identify NSC in the early phase of aSAH.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: